4//SEC Filing
Louis Chrystal 4
Accession 0000950170-25-018119
CIK 0001783328other
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 5:47 PM ET
Size
5.4 KB
Accession
0000950170-25-018119
Insider Transaction Report
Form 4
Louis Chrystal
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-01-03+400,000→ 400,000 totalExercise: $3.06Exp: 2035-01-03→ Voting Common Stock (400,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest and become exercisable with respect to 25% of the shares on the one-year anniversary of January 3, 2025, with the balance vesting thereafter in equal monthly installments over the next 36 months of continuous service to the Issuer.
Documents
Issuer
TScan Therapeutics, Inc.
CIK 0001783328
Entity typeother
Related Parties
1- filerCIK 0002018696
Filing Metadata
- Form type
- 4
- Filed
- Feb 10, 7:00 PM ET
- Accepted
- Feb 11, 5:47 PM ET
- Size
- 5.4 KB